Robot-Assisted versus Laparoscopic-Assisted Gastrectomy among Gastric Cancer Patients: A Retrospective Short-Term Analysis from a Single Institution in China

Table 1

Clinicopathological characteristics of all patients.

Clinicopathological features	LAG ()	RAG ()	value
Gender (male/female)	65/23	24/9	0.900
Age (years)			0.678
ASA (2/3)	73/15	30/3	0.419
BMI (kg/m^2)			0.725
Comorbidity	21 (23.86%)	7 (21.21%)	0.758
Resection type (total/distal)	25/63	7/26	0.424
Reconstruction type (B-I/B-II/R-Y)	19/44/25	10/15/8	0.602
Tumor location (U/M/L)	16/15/57	7/5/21	0.917
Operation time (min)			0.001
Estimated blood loss (ml)			0.005
Tumor size (cm)			0.036
T stage			0.075
T1a	18 (20.45%)	13 (39.39%)
T1b	19 (21.59%)	5 (15.15%)
T2	20 (22.73%)	10 (30.30%)
T3	23 (26.14%)	5 (15.15%)
T4a	8 (9.09%)	0 (0.00%)
N stage			0.636
N0	47 (53.41%)	23 (69.70%)
N1	17 (19.32%)	4 (12.12%)
N2	14 (15.91%)	3 (9.09%)
N3a	9 (10.23%)	3 (9.09%)
N3b	1 (1.14%)	0 (0.00%)
TNM stage			0.168
Ia	30 (34.09%)	16 (48.48%)
Ib	13 (14.77%)	6 (18.18%)
IIa	17 (19.32%)	4 (12.12%)
IIb	7 (7.95%)	5 (15.15%)
IIIa	11 (12.50%)	0 (0.00%)
IIIb	7 (7.95%)	2 (6.06%)
IIIc	3 (3.41%)	0 (0.00%)
Number of harvested LNs			0.008
Number of harvested No. 9 LNs			0.039
Number of harvested suprapancreatic LNs			0.472
Days of the first passing flatus (days)			0.053
Hospital stay after surgery (days)			0.579
Postoperative complications	12 (13.64%)	6 (18.18%)	0.735
30-day readmission after surgery	2 (2.27%)	1 (3.03%)	1.000

, statistical significance.